37.5°C no Namida

Early Breast Cancer Detection With Auria Increases Through Strategic Partnerships

Retrieved on: 
Tuesday, October 31, 2023
Functional medicine, Woman, Alternative medicine, Tears, Partnership, Health, Breast cancer, Accountable care organization, Medical imaging, 37.5°C no Namida

FAYETTEVILLE, Ark., Oct. 31, 2023 /PRNewswire/ -- As breast cancer awareness month comes to a close, the fight for awareness and early-stage detection continues. The impact of Auria, the first at-home biological breast cancer screening test powered by tears, is growing through partnerships with Evexia Diagnostics and Healthyr by closing the gap in screening through biological testing.

Key Points: 
  • FAYETTEVILLE, Ark., Oct. 31, 2023 /PRNewswire/ -- As breast cancer awareness month comes to a close, the fight for awareness and early-stage detection continues.
  • The impact of Auria , the first at-home biological breast cancer screening test powered by tears, is growing through partnerships with Evexia Diagnostics and Healthyr by closing the gap in screening through biological testing.
  • "Thanks to our new partnerships we will be able to offer Auria in thousands of new places and help close the breast cancer gap in care.
  • Our goal is to increase early-stage breast cancer detection, reduce cancer spend, and improve breast health outcomes for all women," said Omid Moghadam, Founder and CEO of Namida.

Namida Wins Top Intelligent Diagnostics Award for Auria® at Prestigious 2023 Edison Awards™ Honors

Retrieved on: 
Tuesday, April 25, 2023
Research, Women, Biotechnology, Health, Consumer, General Health, Other Science, Science, Oncology, Medicine, Education, Marketing, Lab, CSO, Tears, Cancer, Woman, Genentech, 37.5°C no Namida, Pharmacogenomics, Thomas Edison, GRAIL, Gold, Engineering, General Motors, Edison Awards, Pharmaceutical industry

Namida Lab's innovative biological breast cancer screening technology, Auria®, has been awarded the prestigious Gold prize for Intelligent Diagnostics at the 36th annual Edison Awards in Fort Myers, Florida.

Key Points: 
  • Namida Lab's innovative biological breast cancer screening technology, Auria®, has been awarded the prestigious Gold prize for Intelligent Diagnostics at the 36th annual Edison Awards in Fort Myers, Florida.
  • Namida Founder and CEO Omid Moghadam and CSO Dr. Anna Daily, Ph.D., inventor of Auria, accepted the award on behalf of the company.
  • The Edison Awards™, named after the American inventor Thomas Alva Edison, celebrates the best in product and service development, marketing, design, and innovation.
  • With the top prize at the 2023 Edison Awards, the company is well-positioned to continue fighting cancer and saving lives through early detection.